The importance of the tumor microenvironment in the therapeutic management of cancer
- PMID: 26098949
- DOI: 10.1586/14737140.2015.1059279
The importance of the tumor microenvironment in the therapeutic management of cancer
Abstract
Tumor prognosis is generally defined by various tumor parameters. However, it is well known that paracrine, endocrine and cell-cell interactions between the tumor and its microenvironment contribute to its growth. The tumor microenvironment (TME) can also influence disease prognosis and is likely to be considered as an important prognostic factor. In addition, conventional therapies can influence the microenvironment and antitumor immunity. Similarly, the TME will influence the effectiveness of therapy. The purpose of this review is to demonstrate how TME is important in therapeutic management. Key interactions between TME and different cancer therapies as well as their current clinical consequences have been described. More research is needed to establish the important network between tumor cells and their environment to highlight their relationships with conventional therapies and develop global therapeutic strategies.
Keywords: cancer prognosis; conventional therapies; integrated therapy; therapeutic strategies; tumor microenvironment.
Similar articles
-
Chemopreventive agents targeting tumor microenvironment.Life Sci. 2016 Jan 15;145:74-84. doi: 10.1016/j.lfs.2015.12.016. Epub 2015 Dec 8. Life Sci. 2016. PMID: 26679106 Review.
-
Targeting Tumor Microenvironment for Cancer Therapy.Int J Mol Sci. 2019 Feb 15;20(4):840. doi: 10.3390/ijms20040840. Int J Mol Sci. 2019. PMID: 30781344 Free PMC article. Review.
-
Complex interplay between tumor microenvironment and cancer therapy.Front Med. 2018 Aug;12(4):426-439. doi: 10.1007/s11684-018-0663-7. Epub 2018 Aug 10. Front Med. 2018. PMID: 30097962 Review.
-
Improving radioresponse through modification of the tumor immunological microenvironment.Cancer Biother Radiopharm. 2012 Feb;27(1):6-11. doi: 10.1089/cbr.2011.1048. Epub 2012 Jan 12. Cancer Biother Radiopharm. 2012. PMID: 22239431 Review.
-
Targeting the tumor microenvironment by immunotherapy: part 2.Immunotherapy. 2011 Nov;3(11):1385-408. doi: 10.2217/imt.11.112. Immunotherapy. 2011. PMID: 22053888 Review.
Cited by
-
Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME).Heliyon. 2024 Mar 3;10(5):e27480. doi: 10.1016/j.heliyon.2024.e27480. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463798 Free PMC article. Review.
-
A novel prognostic model for predicting patient survival and immunotherapy responsiveness in hepatocellular carcinoma: insights into the involvement of T-cell proliferation.Clin Transl Oncol. 2023 Dec 21. doi: 10.1007/s12094-023-03363-7. Online ahead of print. Clin Transl Oncol. 2023. PMID: 38123874
-
Revealing the potential of necroptosis-related genes in prognosis, immune characteristics, and treatment strategies for head and neck squamous cell carcinoma.Sci Rep. 2023 Nov 21;13(1):20382. doi: 10.1038/s41598-023-47096-7. Sci Rep. 2023. PMID: 37989855 Free PMC article.
-
A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma.Heliyon. 2023 Aug 29;9(9):e19352. doi: 10.1016/j.heliyon.2023.e19352. eCollection 2023 Sep. Heliyon. 2023. PMID: 37810122 Free PMC article.
-
Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters.Cureus. 2023 Sep 5;15(9):e44751. doi: 10.7759/cureus.44751. eCollection 2023 Sep. Cureus. 2023. PMID: 37809246 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
